Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Good Life Plus

    MCap

    GBP12m

    Last close

    GBP0.02

    ▲ 0.40 (22.86%)

    KEFI Gold and Copper

    MCap

    GBP38m

    Last close

    GBP0.01

    ▲ 0.11 (20.00%)

    OSE Immunotherapeutics

    MCap

    EUR134m

    Last close

    EUR6.14

    ▲ 0.68 (12.45%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Executive Interview – Futura Medical

Executive Interview – Futura Medical

The next 12 months should mark the defining events in Futura Medical’s journey towards sustainable profitability. Futura Medical operates with a low fixed-cost base, seeking to outsource most major operations (such as conducting clinical trials, preparing regulatory submissions, formulation and stability testing) and using specialist contractors as appropriate. This ‘virtual’ approach is particularly suitable for a small development player, allowing spending to be tightly controlled with cash outflows occurring only when really needed. With a cash burn of around £2m pa, Futura Medical should be funded through to profitability. The recent £14m placing allows a material acceleration of new product development, notably the pain relief gel portfolio.

< Previous
Next >

You may also be interested in these:

Screenshot 2024-07-01 133526

Real Estate

Regional REIT - executive interview

Industrials

Electro Optic Systems – Brand video

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free